🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Angiosarcoma

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide Prospective Observational Study of Localized Angiosarcoma of Any Site: ProStars NCT06375941n/a19 sites📍 Rozzano📍 Aviano📍 Orbassano Italian Sarcoma Group · Tests: Observational A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma NCT05607095Phase 12 sites📍 Harrison📍 New York Memorial Sloan Kettering Cancer Center · Tests: Lifileucel (LN-144/LN-145) IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) NCT06849986Phase 21 site📍 Shanghai Fudan University · Tests: Tislelizumab+liposomal doxorubicin+ifosfamide Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma NCT07655570Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Ivonescimab Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma NCT06898970Phase 21 site📍 San Francisco Varun Monga, MBBS · Tests: Vusolimogene Oderparepvec (VO), Pembrolizumab Albumin-bound Paclitaxel Combined With Liposomal Doxorubicin in the Treatment of Advanced or Unresectable Angiosarcoma NCT04859465Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Abraxane combined with liposomal doxorubicin NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) NCT06239272Phase 1, Phase 27 sites📍 Atlanta📍 Chicago📍 Baton Rouge St. Jude Children's Research Hospital · Tests: Surgical resection, Proton beam radiation therapy, Pazopanib, Ifosfamide, Doxorubicin Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas NCT04055220NA16 sites📍 Besançon📍 Bordeaux📍 Lille Centre Leon Berard · Tests: Treatment by Regorafenib, Surveillance Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients NCT06673628Phase 26 sites📍 Kashiwa📍 Kyoto📍 Miyazaki National Cancer Center, Japan · Tests: Pembrolizumab plus Lenvatinib A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers NCT06541652n/a40 sites📍 Amiens📍 Angers📍 Beauvais Federation Francophone de Cancerologie Digestive Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients NCT05961761Phase 24 sites📍 Aarhus📍 Herlev📍 Oslo Niels Junker · Tests: Propranolol, Pembrolizumab A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer NCT05859074Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: MQ719, Pembrolizumab I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer NCT01042379Phase 242 sites📍 Birmingham📍 Scottsdale📍 Tucson QuantumLeap Healthcare Collaborative · Tests: Standard Therapy, AMG 386 with or without Trastuzumab, AMG 479 (Ganitumab) plus Metformin, MK-2206 with or without Tras… Cardiac Angiosarcoma International Registry NCT06715579n/a1 site📍 Yerevan Immune Oncology Research Institute Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients NCT07432932n/a1 site📍 London Royal Marsden NHS Foundation Trust · Tests: Observational Translational Study A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites📍 Los Angeles📍 Sarasota📍 St Louis Angiex, Inc. · Tests: AGX101 Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma NCT07007273Phase 23 sites📍 Tampa📍 Columbus📍 Houston H. Lee Moffitt Cancer Center and Research Institute · Tests: Pembrolizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy